Home > Insider Trading > Filing (0001209191-19-005428)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1731348	Tilray Inc.	TLRY	Medicinal Chemicals & Botanical Products (2833)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1746070	Brendan Kennedy	2701 Eastlake Ave E 3Rd Floor Seattle WA 98102	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Class 2 Common Stock	Acquisiton	2019-01-23	375,000	$0.00	389,706	No	4	M	Direct
Class 2 Common Stock	Disposition	2019-01-24	149,916	$74.21	239,790	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Class 2 Common Stock	Restricted Stock Units	Disposition	2019-01-23	375,000	$0.00	375,000	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
375,000	2019-01-23		No	4	M	Direct

Footnotes

Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class 2 Common Stock.
The remaining RSUs will vest quarterly at a rate of 6.25% of the total number of RSUs on each quarterly anniversary of January 1, 2017 (the "Vesting Commencement Date") for so long as the Reporting Person remains in Continuous Service (as defined in the Company's 2018 Equity Incentive Plan), such that the total number of RSUs shall be fully vested on the four-year anniversary of the Vesting Commencement Date.